This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Amgen Inc., Teijin Pharma Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,069 
1 out of 126 Years Active: 2016
Title: Shinji Kakuda: Innovator in Pharmaceutical Chemistry
Introduction
Shinji Kakuda is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic potential.
Latest Patents
Kakuda holds a patent for a pyrazole amide derivative. This novel compound is designed to inhibit RORγ activity, which is crucial in the treatment of various diseases. The patent also encompasses a pharmaceutical composition that includes this compound, highlighting its potential use in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, and cancer.
Career Highlights
Throughout his career, Shinji Kakuda has worked with prominent companies in the pharmaceutical industry. He has been associated with Amgen Inc. and Teijin Pharma Limited, where he has contributed to innovative research and development efforts.
Collaborations
Kakuda has collaborated with several professionals in his field, including Hilary Plake Beck and Shon Booker. These collaborations have likely enhanced his research and broadened the impact of his inventions.
Conclusion
Shinji Kakuda's work in developing innovative pharmaceutical compounds demonstrates his commitment to advancing medical science. His contributions are significant in the ongoing fight against various diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile